This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
|Zacks Rank||Definition||Annualized Return|
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
LCA-Vision Inc. (LCAV)
by James GiaquintoJanuary 09, 2012 | Comments : 0 Recommended this article: (0)
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at email@example.com or call 800-767-3771 ext. 9339.
Furthermore, volume eclipsed 730,000 Monday, compared to the daily average of around 100,000.
LCAV announced some very impressive data last week. In the fourth quarter, procedures jumped by 30% year over year (14,205 vs. 10,891). Same-store procedures advanced by 33%.
The company is still expected to report losses for 2011 and 2012, but, since the above announcement, those losses have narrowed significantly. The Zacks Consensus Estimate for last year is currently a loss of 39 cents, but that has narrowed by 14 cents in just the past 7 days.
As for the current year, the Zacks Consensus Estimate for a 15-cent loss has narrowed by as much as 28 cents in the same timeframe.
It should be noted that there is currently only one analyst covering the company.
LCAV is scheduled to report its fourth-quarter results on Feb. 14. At the moment, the Zacks Consensus Estimate is at a loss of 15 cents per share. Much like the annual expectations, there has been a significant narrowing in the past week.
The company announced a loss of 20 cents per share in its third quarter, which matched the Zacks Consensus Estimate. Revenue improved by 7.5%.
LCAV continues to gain market share, and is also moving to diversify by expanding into cataract and premium intraocular lens (IOL) surgeries. The company said it is adding a co-management offering to provide a referral base for LASIK, cataract and premium IOL patients.
Please login to Zacks.com or register to post a comment.